Global Impurity Control: Genotoxicity, Nitrosamines, and Beyond 2026 Conference

The Global Impurity Control: Genotoxicity, Nitrosamines, and Beyond 2026 Conference brings together pharmaceutical and regulatory experts to advance strategies for controlling genotoxic impurities, nitrosamines, and related contaminants in drug development.

Key Topics

• Genotoxicity testing with in silico modeling and high-throughput screening
• Mass spectrometry and LC-MS/MS for trace impurity quantification and qualification
• Emerging contaminants and novel detection techniques
• Management of nitrosamine risks in drug formulations
• Comprehensive risk assessment and CMC strategies
• In vitro, in vivo, and extractables/leachables testing approaches
• Genotoxic impurities in biopharmaceuticals
• Management of genotoxic impurities in small molecule APIs
• Regulatory compliance and safety considerations

Who should Attend

• Regulatory affairs professionals
• Toxicologists and risk assessors
• Pharmaceutical and formulation scientists
• AI and machine learning experts in drug development
• API manufacturers and biopharmaceutical leaders
• Quality assurance and compliance officers
• Analytical chemists and laboratory technicians
• Research and development teams
• Process development engineers
• Clinical and preclinical researchers
• Regulatory authorities and consultants
• Data scientists focused on pharmaceutical research
• Environmental and sustainability specialists
• Safety and toxicology experts